Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancer.
Thyroid cancer (TC) is a frequently occurring malignant tumor with a rising steadily incidence. microRNA (miRNA/miR)‑193a‑3p is an miRNA that is associated with tumors, playing a crucial role in the genesis and progression of various cancers. However, the expression levels of miR‑193a‑3p and its molecular mechanisms in TC remain to be elucidated. The present study aimed to probe the expression of miR‑193a‑3p and its clinical significance in TC, including its underlying molecular mechanisms. Microarray and RNA sequencing data gathered from three major databases, specifically Gene Expression Omnibus (GEO), ArrayExpress and The Cancer Genome Atlas (TCGA) databases, and the relevant data from the literature were used to examine miR‑193a‑3p expression. Meta‑analysis was also conducted to evaluate the association between clinicopathological parameters and miR‑193a‑3p in 510 TC and 59 normal samples from the TCGA database. miRWalk 3.0, and the TCGA and GEO databases were used to predict the candidate target genes of miR‑193a‑3p. Gene Ontology, Kyoto Encyclopedia of Genes and Genomes and protein‑protein interaction network enrichment analyses were conducted by using the predicted candidate target genes to investigate the underlying carcinogenic mechanisms. A dual luciferase assay was performed to validate the targeting regulatory association between the most important hub gene cyclin D1 (CCND1) and miR‑193a‑3p. miR‑193a‑3p expression was considerably downregulated in TC compared with in the non‑cancer controls (P<0.001). The area under the curve of the summary receiver operating characteristic was 0.80. Downregulation of miR‑193a‑3p was also significantly associated with age, sex and metastasis (P=0.020, 0.044 and 0.048, respectively). Bioinformatics analysis indicated that a low miR‑193a‑3p expression may augment CCND1 expression to affect the biological processes of TC. In addition, CCND1, as a straightforward target, was validated through a dual luciferase assay. miR‑193a‑3p and CCND1 may serve as prognostic biomarkers of TC. Finally, miR‑193a‑3p may possess a crucial role in the genesis and progression of TC by altering the CCND1 expression.
['Li|Xiao-Jiao|XJ|', 'Wen|Rong|R|', 'Wen|Dong-Yue|DY|', 'Lin|Peng|P|', 'Pan|Deng-Hua|DH|', 'Zhang|Li-Jie|LJ|', 'He|Yu|Y|', 'Shi|Lin|L|', 'Qin|Yong-Ying|YY|', 'Lai|Yun-Hui|YH|', 'Lai|Jing-Ni|JN|', 'Yang|Jun-Lin|JL|', 'Lai|Qin-Qiao|QQ|', 'Wang|Jun|J|', 'Ma|Jun|J|', 'Yang|Hong|H|', 'Pang|Yu-Yan|YY|']
D019938:Cyclin D1 D005260:Female D020869:Gene Expression Profiling D015972:Gene Expression Regulation, Neoplastic D006801:Humans D008297:Male D035683:MicroRNAs D009367:Neoplasm Staging D020411:Oligonucleotide Array Sequence Analysis D011379:Prognosis D017423:Sequence Analysis, RNA D016019:Survival Analysis D013964:Thyroid Neoplasms
thyroid cancer microrna-193a-3p cyclin d1 in-house  dual luciferase assay meta-analysis